The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress.


Journal

Pharmacogenomics
ISSN: 1744-8042
Titre abrégé: Pharmacogenomics
Pays: England
ID NLM: 100897350

Informations de publication

Date de publication:
04 2023
Historique:
medline: 18 4 2023
pubmed: 5 4 2023
entrez: 4 4 2023
Statut: ppublish

Résumé

On 8-9 November 2022, the European Society of Pharmacogenomics and Personalised Therapy organized its sixth biennial congress, in Belgrade, Serbia (congress website: www.sspt.rs). The congress aimed to address the current status and future perspectives of pharmacogenomics, share latest knowledge in the field of precision medicine and showcase the implementation of clinical applications in pharmacogenomics/pharmacogenetics. The 2 day congress consisted of 17 lectures given by key-opinion leaders and included a poster session plus discussions. The meeting was a great success by generating an informal environment and enabling the exchange of information between 162 participants from 16 different countries.

Identifiants

pubmed: 37014361
doi: 10.2217/pgs-2023-0013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-246

Auteurs

Ron Hn van Schaik (RH)

Department of Clinical Chemistry, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Vangelis G Manolopoulos (VG)

Department of Pharmacology, Democritus University of Thrace, Alexandroupolis, Greece.

Ann K Daly (AK)

Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Mikko Niemi (M)

Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.

Branka Zukic (B)

Institute of Molecular Genetics & Genetic Engineering, University of Belgrade, Belgrade, Serbia.

George P Patrinos (GP)

Laboratory of Pharmacogenomics & Individualised Therapy, University of Patras, Department of Pharmacy, Patras, Greece.
Department of Genetics & Genomics, United Arab Emirates University, College of Medicine & Health Sciences, Al Ain, Abu Dhabi, UAE.
Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE.

Dragan Primorac (D)

St. Catherine Specialty Hospital, Zagreb, Croatia.

Jesse J Swen (JJ)

Department of Clinical Pharmacology & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

Magnus Ingelman-Sundberg (M)

Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Tiffany Morris (T)

Precision Health & Pharmacogenomics, Illumina, Cambridge, UK.

Espen Molden (E)

Department of Pharmacy, University of Oslo, Oslo, Norway.

Daniel Müller (D)

Department of Psychiatry, University of Toronto, Toronto, Canada.

Sonja Pavlovic (S)

Institute of Molecular Genetics & Genetic Engineering, University of Belgrade, Belgrade, Serbia.

Stefan Russmann (S)

ETH Zürich, Hirslanden Hospitals & drugsafety.ch, Switzerland.

Marc Ansari (M)

Cansearch Research Platform for Pediatric Oncology & Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology & Obstetrics, University of Geneva, Switzerland.

Linda M Henricks (LM)

Division of Pediatric Oncology & Hematology, Department of Women, Child & Adolescent, University Geneva Hospitals, Geneva, Switzerland.

Wout van den Broek (WV)

Department of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands.

Francesco Florindi (F)

Strategy & Partnership, Thermo Fisher Scientific, Brussels, Belgium.

Nada Bozina (N)

Department of Pharmacology, University of Zagreb, Zagreb, Croatia.

Demet Akin (D)

Department of Pharmacology, Bahcesehir University, Istanbul, Turkey.

Lona Christrup (L)

Department of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Adrian Llerena (A)

INUBE Biosanitary University Research Institute, University of Extramedura, Spain.

Cilla Sipeky (C)

Department of Translational Medicine, UCB Biopharma, Waterloo, Belgium.

Sanja Stankovic (S)

Department of Medical Biochemistry, University Clinical Center of Serbia, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH